Home › Nasopharyngeal Carcinoma › California › San Francisco
Nasopharyngeal Carcinoma clinical trials in San Francisco, CA
3 studies for Nasopharyngeal Carcinoma are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
RecruitingPhase 2
- Kaiser Permanente-San Francisco, San Francisco
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
RecruitingPhase 2
- UCSF Medical Center-Mission Bay, San Francisco
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
Recruiting
- University of California, San Francisco, San Francisco
Nasopharyngeal Carcinoma trials in other cities
- Atlanta, GA6 studies
- Houston, TX3 studies
- Richmond, VA3 studies
- Cincinnati, OH3 studies
- Pittsburgh, PA3 studies
- Los Angeles, CA3 studies
- Washington, DC3 studies
- Chicago, IL3 studies
- Charlotte, NC3 studies
- Oklahoma City, OK3 studies
- Milwaukee, WI3 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.